Back to Search
Start Over
Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients
- Source :
- Liver International, Liver International, Wiley-Blackwell, 2016, 36 (3), pp.401-409. ⟨10.1111/liv.12917⟩, Liver international : official journal of the International Association for the Study of the Liver, vol 36, iss 3, Liver International, 2016, 36 (3), pp.401-409. ⟨10.1111/liv.12917⟩
- Publication Year :
- 2016
- Publisher :
- HAL CCSD, 2016.
-
Abstract
- International audience; BACKGROUND AND AIMS: The beneficial effect of one graft on another has been reported in combined transplantation but the associated mechanisms and biological influence of each graft have not yet been established. METHODS: In multiple analyses, we explored the PBMC phenotype and signature of 45 immune-related messenger RNAs and 754 microRNAs from a total of 235 patients, including combined liver-kidney transplant recipients (CLK), patients with a liver (L-STA) or kidney (K-STA) graft only under classical immunosuppression and patients with tolerated liver (L-TOL) or kidney grafts (K-TOL). RESULTS: CLK show an intermediary phenotype with a higher percentage of peripheral CD19(+) CD24(+) CD38(Low) memory B cells and Helios(+) Treg cells, two features associated with tolerance profiles, compared to L-STA and K-STA (P \textless 0.05, P \textless 0.01). Very few miRNA were significantly differentially expressed in CLK vs. K-STA and even fewer when compared to L-STA (35 and 8, P \textless 0.05). Finally, CLK are predicted to share common miRNA targets with K-TOL and even more with L-TOL (344 and 411, P = 0.005). Altogether CLK display an intermediary phenotype and gene profile, which is closer to that of liver transplant patients, with possible similarities with the profiles of tolerant patients. CONCLUSION: These data suggest that CLK patients show the immunological influence of both allografts with liver having a greater influence
- Subjects :
- 0301 basic medicine
Graft Rejection
Male
Kidney Disease
medicine.medical_treatment
[SDV]Life Sciences [q-bio]
Messenger
030230 surgery
CD38
Liver transplantation
0302 clinical medicine
Leukocytes
Kidney transplantation
Oligonucleotide Array Sequence Analysis
liver transplantation
microRNA
Liver Disease
Graft Survival
Immunosuppression
Middle Aged
Allografts
Phenotype
3. Good health
Treatment Outcome
Transplantation Tolerance
Female
France
Immunosuppressive Agents
Biotechnology
Genetic Markers
Genotype
phenotype
Mononuclear
Clinical Sciences
Renal and urogenital
kidney transplantation
Biology
Peripheral blood mononuclear cell
Article
03 medical and health sciences
Clinical Research
medicine
Genetics
Humans
RNA, Messenger
human
Aged
Transplantation
Hepatology
Gastroenterology & Hepatology
Gene Expression Profiling
Organ Transplantation
medicine.disease
Gene expression profiling
MicroRNAs
030104 developmental biology
Gene Expression Regulation
Spain
Immunology
Leukocytes, Mononuclear
gene expression
RNA
San Francisco
Digestive Diseases
combined transplantation
Subjects
Details
- Language :
- English
- ISSN :
- 14783223 and 14783231
- Database :
- OpenAIRE
- Journal :
- Liver International, Liver International, Wiley-Blackwell, 2016, 36 (3), pp.401-409. ⟨10.1111/liv.12917⟩, Liver international : official journal of the International Association for the Study of the Liver, vol 36, iss 3, Liver International, 2016, 36 (3), pp.401-409. ⟨10.1111/liv.12917⟩
- Accession number :
- edsair.doi.dedup.....e8ba19a36f0272f061952104a7852889
- Full Text :
- https://doi.org/10.1111/liv.12917⟩